Mintz represented ArriVent Biopharma, Inc. on the deal. ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155...
Mintz represented ArriVent Biopharma, Inc. on the deal. ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155...
You must be a Standard 1 Year member to access this content.